...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Expectations for the AGM?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I left a question as follows.What is the path you see for the company?If we are to continue ax an academic entity endless trials will you give liquidity by listing the shares.?

This I see as giving us a clear picture of the boards intent.Feel free to add to this 

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply